Motco Boosted Cvs Health (CVS) Holding By $3.24 Million; Mays J W (MAYS) Has 0.5 Sentiment

May 23, 2018 - By Hazel Jackson

CVS Health Corporation (NYSE:CVS) Logo

Motco increased Cvs Health Corporation (CVS) stake by 82.44% reported in 2017Q4 SEC filing. Motco acquired 44,952 shares as Cvs Health Corporation (CVS)’s stock declined 17.45%. The Motco holds 99,477 shares with $7.21 million value, up from 54,525 last quarter. Cvs Health Corporation now has $66.53B valuation. The stock decreased 0.27% or $0.18 during the last trading session, reaching $65.44. About 1.93 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 23, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Mays J W Inc (MAYS) investors sentiment decreased to 0.5 in Q4 2017. It’s down -0.50, from 1 in 2017Q3. The ratio fall, as 1 active investment managers increased or opened new holdings, while 2 decreased and sold holdings in Mays J W Inc. The active investment managers in our database reported: 66,056 shares, down from 68,071 shares in 2017Q3. Also, the number of active investment managers holding Mays J W Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 2 Increased: 1 New Position: 0.

The stock increased 4.33% or $1.65 during the last trading session, reaching $39.75. About 3,700 shares traded or 507.55% up from the average. J.W. Mays, Inc. (MAYS) has declined 22.92% since May 23, 2017 and is downtrending. It has underperformed by 34.47% the S&P500.

Raffles Associates Lp holds 1.84% of its portfolio in J.W. Mays, Inc. for 44,939 shares. Blackrock Inc. owns 177 shares or 0% of their US portfolio. Moreover, Dimensional Fund Advisors Lp has 0% invested in the company for 5,258 shares. The New York-based Morgan Stanley has invested 0% in the stock. Tower Research Capital Llc (Trc), a New York-based fund reported 71 shares.

J.W. Mays, Inc. owns, operates, and leases commercial real estate properties in the United States. The company has market cap of $80.13 million. The Company’s properties are located in Brooklyn, Jamaica, Fishkill, Levittown, and Massapequa of New York, as well as Circleville of Ohio. It has a 20.09 P/E ratio.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: “We Are Playing The CVS Hand” on May 11, 2018, also with their article: “CVS-Aetna merger is not about the minute clinic, Aetna CEO says” published on May 22, 2018, published: “Trade Mistake 3: CVS Boredom Trade” on May 09, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” published on May 04, 2018 as well as‘s news article titled: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” with publication date: April 26, 2018.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. Needham maintained it with “Buy” rating and $88 target in Tuesday, January 2 report. The firm earned “Hold” rating on Thursday, August 20 by Deutsche Bank. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Monday, September 25 by Robert W. Baird. Leerink Swann maintained CVS Health Corporation (NYSE:CVS) on Tuesday, November 21 with “Buy” rating. Citigroup maintained it with “Neutral” rating and $87 target in Thursday, August 17 report. The rating was maintained by Deutsche Bank with “Hold” on Wednesday, July 22. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Jefferies on Thursday, May 12. The rating was downgraded by Jefferies to “Hold” on Monday, December 12. SunTrust maintained CVS Health Corporation (NYSE:CVS) rating on Thursday, January 4. SunTrust has “Buy” rating and $90.0 target. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Friday, September 15.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Glovista Investments Lc holds 0.09% in CVS Health Corporation (NYSE:CVS) or 6,150 shares. Bnp Paribas Asset Holdg reported 543,829 shares. Swiss Commercial Bank has 0.3% invested in CVS Health Corporation (NYSE:CVS). Invsts has invested 0.18% in CVS Health Corporation (NYSE:CVS). St James Invest Co Ltd Com has invested 6.59% in CVS Health Corporation (NYSE:CVS). Philadelphia Trust Co owns 33,844 shares. 1,056 are owned by Gemmer Asset Management Ltd Limited Liability Company. Baldwin Mgmt Limited Company invested in 9,710 shares. First Foundation Advisors reported 8,013 shares. Groesbeck Inv Nj has invested 0.73% in CVS Health Corporation (NYSE:CVS). Qci Asset Mgmt New York invested in 0% or 499 shares. North Amer Mgmt Corporation holds 0.14% of its portfolio in CVS Health Corporation (NYSE:CVS) for 12,280 shares. 55,454 are owned by Kayne Anderson Rudnick Inv Mgmt Limited Liability. Coho Partners Ltd reported 2.04M shares. Peoples Service, Pennsylvania-based fund reported 705 shares.

Motco decreased Aqua America Inc. (NYSE:WTR) stake by 9,361 shares to 152,974 valued at $6.00M in 2017Q4. It also reduced Cisco Systems Inc (NASDAQ:CSCO) stake by 9,128 shares and now owns 259,134 shares. Intercontinental Exchange Group Inc (NYSE:ICE) was reduced too.

Since February 16, 2018, it had 2 insider buys, and 1 sale for $713,454 activity. $619,900 worth of CVS Health Corporation (NYSE:CVS) was bought by BROWN C DAVID II on Friday, May 4. Foulkes Helena sold $1.42 million worth of stock. DORMAN DAVID W also bought $1.51M worth of CVS Health Corporation (NYSE:CVS) shares.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: